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Background
A fundamental question in biology is how an organism’s
genome controls cellular differentiation and identity to
produce numerous distinct cell types. At the epigenome
level, this is partially influenced by cell type specific regula-
tory regions marked by accessible chromatin. Recent gen-
ome-wide maps of chromatin modifications and DNA
associated proteins have identified over a million candidate
regulatory elements in the human genome. These DNA
sequence elements are proposed to drive the activation or
repression of nearby genes, however new tools are needed
to do a thorough and systematic functional analysis of
these elements in an endogenous context.
Materials and methods
To directly test distal elements in a loss of function man-
ner, we have fused the chromatin modifying enzyme lysine
specific demethylase 1 (LSD1, also known as KDM1A) to
transcription activator-like (TAL) effector DNA binding
proteins. The TAL:LSD1 fusions are designed to specifi-
cally bind target DNA sequences and alter the nearby
chromatin state, specifically demethylation of histone H3
lysine 4 di and mono-methylation (H3K4me2/1), a mark
of distal enhancers. We have designed TALs to target over
50 putative distal enhancers. These constructs were indivi-
dually transfected into the erythroleukemic cell line K562,
after which we examined changes in H3K4me2 and
H3K27acetylation by ChIP, or examined gene expression
changes by RNA-seq. Additionally we designed TALs
fused to a 3X FLAG epitope to do ChIP-seq analysis and
determine the specificity of TAL targeting.
Results
We show using TAL:3XFLAG ChIP-seq that binding of
TALs is virtually exclusive to their target sequence. We
show the TAL:LSD1 fusions have the ability to specifi-
cally decrease H3K4me2, as well as H3K27acetyl,
another mark of distal enhancers, at their intended tar-
get sites. We find roughly 50% of TALs significantly
reduce the chromatin modifications at the target enhan-
cer, but not at non-target control enhancers. For a sub-
set of these TAL:LSD1 fusions, we used RNA-seq to
identify a nearby gene that is downregulated upon loss
of the chromatin state at the enhancer. These nearby
target genes show a range of decreased expression,
allowing us to relatively quantitate the contribution on
transcriptional activation of the target enhancer.
Conclusions
By utilizing TAL DNA binding proteins fused to chro-
matin modifying enzymes, we can precisely alter the
endogenous chromatin state of a locus. We use this to
direct enzymes that remove active chromatin marks.
This is in effect, creating a method to do “epigenetic
knockdowns” analogous to the commonly used method
of genetic knockdowns. The removal of active chroma-
tin marks disrupts the function of distal enhancers,
thereby allowing us to identify the promoters they regu-
late, and quantify the enhancer’s contribution to its tar-
get gene’s expression.
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